董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Miguel A. Lopez | 男 | Director | 67 | 10.38万美元 | 未持股 | 2026-04-15 |
| Miguel A. Lopez | 男 | Director | 66 | 未披露 | 未持股 | 2026-04-15 |
| Laura Angelini | 女 | Director | 62 | 16.52万美元 | 2.70 | 2026-04-15 |
| Richard E. Kuntz | 男 | Director | 69 | 未披露 | 未持股 | 2026-04-15 |
| Kirsten Newquist | 女 | Chief Executive Officer and Director | 59 | 61.64万美元 | 10.89 | 2026-04-15 |
| James E. Ousley | 男 | Chair | 80 | 19.67万美元 | 25.78 | 2026-04-15 |
| Richard E. Kuntz | 男 | Director | 69 | 15.91万美元 | 2.70 | 2026-04-15 |
| Gary Kremen | 男 | Director | 62 | 13.33万美元 | 28.47 | 2026-04-15 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Edward Kirnbauer | 男 | Chief Financial Officer and Secretary | 61 | 51.91万美元 | 未持股 | 2026-04-15 |
| Kirsten Newquist | 女 | Chief Executive Officer and Director | 59 | 61.64万美元 | 10.89 | 2026-04-15 |
董事简历
中英对照 | 中文 | 英文- Miguel A. Lopez
-
Miguel A. Lopez， 2014年2月以来，他一直担任公司的副总裁和首席财务官。他此前曾任职Aricent Group公司，担任首席财务官（从2011年10月到2013年11月）。他也曾担任Cisco Systems公司的负责财务和运营的副总裁（从2007年到2011年）、Tyco International公司的消防和安全部门的负责业务发展的副总裁（从2005年到2007年）、ADT Security Systems North America公司的首席财务官（从2003年到2004年）。他的职业生涯始于担任KPMG公司的审计师，随后任职IBM公司，在那里他曾担任IBM Brazil公司的首席财务官，负责拉丁美洲的个人电脑，管理拉丁美洲并购活动，并担任多种定价和渠道策略、财务计划和分析、信贷和财政相关的其它职务。
Miguel A. Lopez, Senior Vice President and Chief Financial Officer since February 2014. Formerly with Aricent Group, as Chief Financial Officer from October 2011 to November 2013; with Cisco Systems, as Vice President of Finance and Operations from 2007 to 2011; with Tyco International, as Vice President, Business Development of the Fire and Security division from 2005 to 2007 and as Chief Financial Officer for ADT Security Systems North America from 2003 to 2004. Mr. Lopez began his career as an auditor at KPMG, and thereafter was at IBM, where he was Chief Financial Officer for IBM Brazil and for Latin America Personal Computers, managed Latin America merger and acquisition activity and held various other positions related to pricing and channel strategy, financial planning and analysis, credit and treasury. - Miguel A. Lopez， 2014年2月以来，他一直担任公司的副总裁和首席财务官。他此前曾任职Aricent Group公司，担任首席财务官（从2011年10月到2013年11月）。他也曾担任Cisco Systems公司的负责财务和运营的副总裁（从2007年到2011年）、Tyco International公司的消防和安全部门的负责业务发展的副总裁（从2005年到2007年）、ADT Security Systems North America公司的首席财务官（从2003年到2004年）。他的职业生涯始于担任KPMG公司的审计师，随后任职IBM公司，在那里他曾担任IBM Brazil公司的首席财务官，负责拉丁美洲的个人电脑，管理拉丁美洲并购活动，并担任多种定价和渠道策略、财务计划和分析、信贷和财政相关的其它职务。
- Miguel A. Lopez, Senior Vice President and Chief Financial Officer since February 2014. Formerly with Aricent Group, as Chief Financial Officer from October 2011 to November 2013; with Cisco Systems, as Vice President of Finance and Operations from 2007 to 2011; with Tyco International, as Vice President, Business Development of the Fire and Security division from 2005 to 2007 and as Chief Financial Officer for ADT Security Systems North America from 2003 to 2004. Mr. Lopez began his career as an auditor at KPMG, and thereafter was at IBM, where he was Chief Financial Officer for IBM Brazil and for Latin America Personal Computers, managed Latin America merger and acquisition activity and held various other positions related to pricing and channel strategy, financial planning and analysis, credit and treasury.
- Miguel A. Lopez
-
Miguel A. Lopez自2025年4月起担任公司董事。Lopez先生目前在消费电子和摄像头技术公司GoPro，Inc.（纳斯达克：GPRO）的董事会任职。他在全球电动汽车公司Zeekr Group（NYSE：ZK）的董事会任职至2025年12月。2020年6月至2024年11月，任职于通信软件和网络解决方案提供商Ribbon Communications（纳斯达克：RBBN），担任首席财务官。在此之前，Lopez先生曾于2018年4月至2020年5月在户外运动和休闲产品的设计者和制造商Vista Outdoor Inc.（NYSE：VSTO）、2016年2月至2017年7月在企业数据管理软件公司Veritas Technologies LLC、2014年2月至2016年1月在国防和通信技术公司Harris Corporation（现为L3 Harris Technologies，Inc.（NYSE：LHX））以及2011年11月至2014年1月在全球工程服务公司Aricent Group担任首席财务官。Lopez先生还曾在全球网络和IT公司思科公司（纳斯达克：CSCO）、安全和消防公司Tyco Fire & Security以及跨国技术和咨询公司国际商业机器公司（IBM）（纽约证券交易所代码：IBM）担任高级财务领导职务。
Miguel A. Lopez has served as a director of the Company since April 2025. Mr. Lopez currently serves on the board of directors of GoPro, Inc. (Nasdaq: GPRO), a consumer electronics and camera technology company. He served on the board of directors of Zeekr Group (NYSE: ZK), a global electric vehicle company, until December 2025. From June 2020 to November 2024, he served as Chief Financial Officer at Ribbon Communications (Nasdaq: RBBN), a provider of communications software and network solutions. Prior to that, Mr. Lopez served as Chief Financial Officer at Vista Outdoor Inc. (NYSE: VSTO), a designer and manufacturer of outdoor sports and recreation products, from April 2018 to May 2020, Veritas Technologies LLC, an enterprise data management software company, from February 2016 to July 2017, and Harris Corporation (currently L3 Harris Technologies, Inc. (NYSE: LHX)), a defense and communications technology company, from February 2014 to January 2016, and Aricent Group, a global engineering services company, from November 2011 to January 2014. Mr. Lopez has also held senior financial leadership roles at Cisco Systems, Inc. (Nasdaq: CSCO), a global networking and IT company, Tyco Fire & Security, a security and fire protection company, and International Business Machines Corporation (IBM) (NYSE: IBM), a multinational technology and consulting company. - Miguel A. Lopez自2025年4月起担任公司董事。Lopez先生目前在消费电子和摄像头技术公司GoPro，Inc.（纳斯达克：GPRO）的董事会任职。他在全球电动汽车公司Zeekr Group（NYSE：ZK）的董事会任职至2025年12月。2020年6月至2024年11月，任职于通信软件和网络解决方案提供商Ribbon Communications（纳斯达克：RBBN），担任首席财务官。在此之前，Lopez先生曾于2018年4月至2020年5月在户外运动和休闲产品的设计者和制造商Vista Outdoor Inc.（NYSE：VSTO）、2016年2月至2017年7月在企业数据管理软件公司Veritas Technologies LLC、2014年2月至2016年1月在国防和通信技术公司Harris Corporation（现为L3 Harris Technologies，Inc.（NYSE：LHX））以及2011年11月至2014年1月在全球工程服务公司Aricent Group担任首席财务官。Lopez先生还曾在全球网络和IT公司思科公司（纳斯达克：CSCO）、安全和消防公司Tyco Fire & Security以及跨国技术和咨询公司国际商业机器公司（IBM）（纽约证券交易所代码：IBM）担任高级财务领导职务。
- Miguel A. Lopez has served as a director of the Company since April 2025. Mr. Lopez currently serves on the board of directors of GoPro, Inc. (Nasdaq: GPRO), a consumer electronics and camera technology company. He served on the board of directors of Zeekr Group (NYSE: ZK), a global electric vehicle company, until December 2025. From June 2020 to November 2024, he served as Chief Financial Officer at Ribbon Communications (Nasdaq: RBBN), a provider of communications software and network solutions. Prior to that, Mr. Lopez served as Chief Financial Officer at Vista Outdoor Inc. (NYSE: VSTO), a designer and manufacturer of outdoor sports and recreation products, from April 2018 to May 2020, Veritas Technologies LLC, an enterprise data management software company, from February 2016 to July 2017, and Harris Corporation (currently L3 Harris Technologies, Inc. (NYSE: LHX)), a defense and communications technology company, from February 2014 to January 2016, and Aricent Group, a global engineering services company, from November 2011 to January 2014. Mr. Lopez has also held senior financial leadership roles at Cisco Systems, Inc. (Nasdaq: CSCO), a global networking and IT company, Tyco Fire & Security, a security and fire protection company, and International Business Machines Corporation (IBM) (NYSE: IBM), a multinational technology and consulting company.
- Laura Angelini
-
Laura Angelini自2022年10月起担任公司董事。Angelini女士于2016年10月至2021年7月在医疗保健公司百特国际有限公司（纽约证券交易所代码：BAX）担任肾脏护理全球业务部门总经理。在此之前，Angelini女士曾于1991年7月至2016年9月在医疗保健公司强生（NYSE：JNJ）担任多个职务，包括2013年至2016年担任Vision Care北美和全球特许经营发展总裁，2012年至2013年担任Ethicon全球战略营销副总裁，2010年至2011年担任东欧医疗器械与诊断副总裁。在她的职业生涯中，Angelini女士跨全球职能扩展业务，领导盈利能力和市场领先表现的战略设计，并为医疗保健和医疗设备的数字化转型制定创新战略。Angelini女士目前担任特种电子元器件的全球供应商诺尔斯公司（NYSE：KN）、注塑封装和组件制造商Technimark LLC以及销售、营销和支持服务集团DCC PLC的董事会成员，并担任杰克逊维尔大学董事会成员。Angelini女士在意大利罗马的La Sapienza大学获得学士学位。
Laura Angelini has served as a director of the Company since October 2022. Ms. Angelini served as General Manager of the Renal Care Global Business Unit at Baxter International Inc. (NYSE: BAX), a healthcare company, from October 2016 to July 2021. Prior to that, Ms. Angelini served in various roles at Johnson & Johnson (NYSE: JNJ), a healthcare company, from July 1991 to September 2016, including as President of North America and Global Franchise Development of Vision Care from 2013 to 2016, Vice President of Global Strategic Marketing of Ethicon from 2012 to 2013, and Vice President of Medical Devices & Diagnostics of Eastern Europe from 2010 to 2011. Over the course of her career, Ms. Angelini scaled businesses across global functions, led strategy design for profitability and market leading performance, and created innovation strategies for digital transformation in healthcare and medical devices. Ms. Angelini currently serves as a member of the board of directors of Knowles Corporation (NYSE: KN), a global provider of specialty electronic components, Technimark LLC, a manufacturer of injection molded packaging and components, DCC plc, a sales, marketing and support services group, and as a member of the board of trustees of Jacksonville University. Ms. Angelini received a bachelor's degree from University La Sapienza, Rome Italy. - Laura Angelini自2022年10月起担任公司董事。Angelini女士于2016年10月至2021年7月在医疗保健公司百特国际有限公司（纽约证券交易所代码：BAX）担任肾脏护理全球业务部门总经理。在此之前，Angelini女士曾于1991年7月至2016年9月在医疗保健公司强生（NYSE：JNJ）担任多个职务，包括2013年至2016年担任Vision Care北美和全球特许经营发展总裁，2012年至2013年担任Ethicon全球战略营销副总裁，2010年至2011年担任东欧医疗器械与诊断副总裁。在她的职业生涯中，Angelini女士跨全球职能扩展业务，领导盈利能力和市场领先表现的战略设计，并为医疗保健和医疗设备的数字化转型制定创新战略。Angelini女士目前担任特种电子元器件的全球供应商诺尔斯公司（NYSE：KN）、注塑封装和组件制造商Technimark LLC以及销售、营销和支持服务集团DCC PLC的董事会成员，并担任杰克逊维尔大学董事会成员。Angelini女士在意大利罗马的La Sapienza大学获得学士学位。
- Laura Angelini has served as a director of the Company since October 2022. Ms. Angelini served as General Manager of the Renal Care Global Business Unit at Baxter International Inc. (NYSE: BAX), a healthcare company, from October 2016 to July 2021. Prior to that, Ms. Angelini served in various roles at Johnson & Johnson (NYSE: JNJ), a healthcare company, from July 1991 to September 2016, including as President of North America and Global Franchise Development of Vision Care from 2013 to 2016, Vice President of Global Strategic Marketing of Ethicon from 2012 to 2013, and Vice President of Medical Devices & Diagnostics of Eastern Europe from 2010 to 2011. Over the course of her career, Ms. Angelini scaled businesses across global functions, led strategy design for profitability and market leading performance, and created innovation strategies for digital transformation in healthcare and medical devices. Ms. Angelini currently serves as a member of the board of directors of Knowles Corporation (NYSE: KN), a global provider of specialty electronic components, Technimark LLC, a manufacturer of injection molded packaging and components, DCC plc, a sales, marketing and support services group, and as a member of the board of trustees of Jacksonville University. Ms. Angelini received a bachelor's degree from University La Sapienza, Rome Italy.
- Richard E. Kuntz
-
Richard E. Kuntz自2022年10月起担任公司董事。Kuntz博士于2015年1月至2022年5月担任医疗器械公司美敦力 PLC的高级副总裁、首席医学和科学官，并于2009年8月至2014年12月担任美敦力，Inc.的高级副总裁。在此之前，他于2005年10月至2009年8月担任高级副总裁兼美敦力神经调节总裁。在任职于美敦力 17年之前，Kuntz博士是哈佛大学临床研究所的创始人和首席科学官，还曾担任哈佛大学医学院医学副教授、临床生物识别学分部主任以及波士顿布莱根妇女医院心血管疾病分部的介入心脏病专家。Kuntz博士目前还自2022年3月起担任医疗技术公司ZimVie Inc.（纳斯达克：ZIMV）的董事会成员，自2022年10月起担任瑞典医疗技术公司BactiGuard Holding AB，自2023年5月起担任生物制药公司DiaMedica Therapeutics，Inc.（纳斯达克：DMAC）的董事会成员。此外，Kuntz博士目前还担任私营公司的董事会成员，这些公司包括自2022年8月起担任数字健康监测系统公司Rockley Photonics控股有限公司、自2022年10月起担任医疗技术制造公司Cognito Therapeutics Inc.以及自2024年1月起担任医疗技术公司Endospan Ltd.。Kuntz博士毕业于迈阿密大学，并在凯斯西储大学医学院获得医学学位。Kuntz博士在哈佛大学T.H. Chan公共卫生学院获得生物统计学硕士学位。
Richard E. Kuntz has served as a director of the Company since October 2022. Dr. Kuntz has served as Senior Vice President, Chief Medical and Scientific Officer of Medtronic plc, a medical device company, from January 2015 to May 2022, and of Medtronic, Inc. from August 2009 to December 2014. Prior to that, he was Senior Vice President and President of Medtronic Neuromodulation from October 2005 to August 2009. Prior to his 17 years at Medtronic, Dr. Kuntz was the Founder and Chief Scientific Officer of the Harvard Clinical Research Institute and he also served as Associate Professor of Medicine at Harvard Medical School, Chief of the Division of Clinical Biometrics, and an interventional cardiologist in the division of cardiovascular diseases at the Brigham and Women's Hospital in Boston. Dr. Kuntz also currently serves as a member of the board of directors of ZimVie Inc. (Nasdaq: ZIMV), a medical technology company since March 2022, Bactiguard Holding AB, a Swedish medical technology company, since October 2022, and DiaMedica Therapeutics, Inc. (Nasdaq: DMAC), a biopharmaceutical company, since May 2023. In addition, Dr. Kuntz currently serves as a member of the board of directors for private companies including Rockley Photonics Holdings Ltd, a digital health monitoring systems company, since August 2022, Cognito Therapeutics Inc., a medical technology manufacturing company, since October 2022, and Endospan Ltd., a medical technology company, since January 2024. Dr. Kuntz graduated from Miami University and received his medical degree from Case Western Reserve University School of Medicine. Dr. Kuntz received his M.S. in biostatistics from the Harvard T.H. Chan School of Public Health. - Richard E. Kuntz自2022年10月起担任公司董事。Kuntz博士于2015年1月至2022年5月担任医疗器械公司美敦力 PLC的高级副总裁、首席医学和科学官，并于2009年8月至2014年12月担任美敦力，Inc.的高级副总裁。在此之前，他于2005年10月至2009年8月担任高级副总裁兼美敦力神经调节总裁。在任职于美敦力 17年之前，Kuntz博士是哈佛大学临床研究所的创始人和首席科学官，还曾担任哈佛大学医学院医学副教授、临床生物识别学分部主任以及波士顿布莱根妇女医院心血管疾病分部的介入心脏病专家。Kuntz博士目前还自2022年3月起担任医疗技术公司ZimVie Inc.（纳斯达克：ZIMV）的董事会成员，自2022年10月起担任瑞典医疗技术公司BactiGuard Holding AB，自2023年5月起担任生物制药公司DiaMedica Therapeutics，Inc.（纳斯达克：DMAC）的董事会成员。此外，Kuntz博士目前还担任私营公司的董事会成员，这些公司包括自2022年8月起担任数字健康监测系统公司Rockley Photonics控股有限公司、自2022年10月起担任医疗技术制造公司Cognito Therapeutics Inc.以及自2024年1月起担任医疗技术公司Endospan Ltd.。Kuntz博士毕业于迈阿密大学，并在凯斯西储大学医学院获得医学学位。Kuntz博士在哈佛大学T.H. Chan公共卫生学院获得生物统计学硕士学位。
- Richard E. Kuntz has served as a director of the Company since October 2022. Dr. Kuntz has served as Senior Vice President, Chief Medical and Scientific Officer of Medtronic plc, a medical device company, from January 2015 to May 2022, and of Medtronic, Inc. from August 2009 to December 2014. Prior to that, he was Senior Vice President and President of Medtronic Neuromodulation from October 2005 to August 2009. Prior to his 17 years at Medtronic, Dr. Kuntz was the Founder and Chief Scientific Officer of the Harvard Clinical Research Institute and he also served as Associate Professor of Medicine at Harvard Medical School, Chief of the Division of Clinical Biometrics, and an interventional cardiologist in the division of cardiovascular diseases at the Brigham and Women's Hospital in Boston. Dr. Kuntz also currently serves as a member of the board of directors of ZimVie Inc. (Nasdaq: ZIMV), a medical technology company since March 2022, Bactiguard Holding AB, a Swedish medical technology company, since October 2022, and DiaMedica Therapeutics, Inc. (Nasdaq: DMAC), a biopharmaceutical company, since May 2023. In addition, Dr. Kuntz currently serves as a member of the board of directors for private companies including Rockley Photonics Holdings Ltd, a digital health monitoring systems company, since August 2022, Cognito Therapeutics Inc., a medical technology manufacturing company, since October 2022, and Endospan Ltd., a medical technology company, since January 2024. Dr. Kuntz graduated from Miami University and received his medical degree from Case Western Reserve University School of Medicine. Dr. Kuntz received his M.S. in biostatistics from the Harvard T.H. Chan School of Public Health.
- Kirsten Newquist
-
克尔斯滕·纽奎斯特（Kirsten Newquist）自2024年9月起担任公司首席执行官和董事。在此之前的2024年4月至2024年9月，她担任公司总裁，物联网解决方案。在加入公司之前，她在全球材料科学和数字身份识别解决方案公司艾利丹尼森公司（纽约证券交易所代码：AVY）担任越来越高级的职务，包括2022年10月至2023年9月在艾利丹尼森 Smartrac担任全球医疗保健和产品线管理全球副总裁，2016年6月至2022年10月在艾利丹尼森 Medical担任全球副总裁/总经理，2011年6月至2016年6月在艾利丹尼森 Medical担任全球业务发展副总裁，2007年5月至2011年6月在艾利丹尼森公司担任新增长平台总监。在加入艾利丹尼森之前，Newquist女士于2005年3月至2007年5月期间担任私人投资公司Copia Associates LLC的董事。2001年8月至2005年1月，Newquist女士在Ancora Management Group担任企业发展副总裁，该公司是一家邮件服务公司，于2004年11月被全球航运和邮件公司必能宝公司（NYSE：PBI）收购。她还曾于1990年1月至1996年8月在Iwerks Entertainment担任项目管理总监，Iwerks Entertainment是一家基于软件的娱乐景点的设计者和制造商。
Kirsten Newquist has served as the Company's Chief Executive Officer and as a director of the Company since September 2024. Prior to that, from April 2024 to September 2024, she served as the Company's President, IoT Solutions. Prior to joining the Company, she held increasingly senior roles at Avery Dennison Corporation (NYSE: AVY), a global materials science and digital identification solutions company, including as Global Vice President, Global Healthcare and Product Line Management at Avery Dennison Smartrac from October 2022 to September 2023, Global Vice President/General Manager at Avery Dennison Medical from June 2016 to October 2022, Vice President, Global Business Development at Avery Dennison Medical from June 2011 to June 2016, and Director of New Growth Platforms at Avery Dennison Corporation from May 2007 to June 2011. Prior to Avery Dennison, Ms. Newquist served as a Director at Copia Associates LLC, a private investment firm, from March 2005 to May 2007. From August 2001 to January 2005, Ms. Newquist served as Vice President, Corporate Development at Ancora Management Group, a mail services company that was acquired by Pitney Bowes Inc. (NYSE: PBI), a global shipping and mailing company, in November 2004. She also served as Director of Project Management at Iwerks Entertainment, a designer and manufacturer of software based entertainment attractions, from January 1990 to August 1996. - 克尔斯滕·纽奎斯特（Kirsten Newquist）自2024年9月起担任公司首席执行官和董事。在此之前的2024年4月至2024年9月，她担任公司总裁，物联网解决方案。在加入公司之前，她在全球材料科学和数字身份识别解决方案公司艾利丹尼森公司（纽约证券交易所代码：AVY）担任越来越高级的职务，包括2022年10月至2023年9月在艾利丹尼森 Smartrac担任全球医疗保健和产品线管理全球副总裁，2016年6月至2022年10月在艾利丹尼森 Medical担任全球副总裁/总经理，2011年6月至2016年6月在艾利丹尼森 Medical担任全球业务发展副总裁，2007年5月至2011年6月在艾利丹尼森公司担任新增长平台总监。在加入艾利丹尼森之前，Newquist女士于2005年3月至2007年5月期间担任私人投资公司Copia Associates LLC的董事。2001年8月至2005年1月，Newquist女士在Ancora Management Group担任企业发展副总裁，该公司是一家邮件服务公司，于2004年11月被全球航运和邮件公司必能宝公司（NYSE：PBI）收购。她还曾于1990年1月至1996年8月在Iwerks Entertainment担任项目管理总监，Iwerks Entertainment是一家基于软件的娱乐景点的设计者和制造商。
- Kirsten Newquist has served as the Company's Chief Executive Officer and as a director of the Company since September 2024. Prior to that, from April 2024 to September 2024, she served as the Company's President, IoT Solutions. Prior to joining the Company, she held increasingly senior roles at Avery Dennison Corporation (NYSE: AVY), a global materials science and digital identification solutions company, including as Global Vice President, Global Healthcare and Product Line Management at Avery Dennison Smartrac from October 2022 to September 2023, Global Vice President/General Manager at Avery Dennison Medical from June 2016 to October 2022, Vice President, Global Business Development at Avery Dennison Medical from June 2011 to June 2016, and Director of New Growth Platforms at Avery Dennison Corporation from May 2007 to June 2011. Prior to Avery Dennison, Ms. Newquist served as a Director at Copia Associates LLC, a private investment firm, from March 2005 to May 2007. From August 2001 to January 2005, Ms. Newquist served as Vice President, Corporate Development at Ancora Management Group, a mail services company that was acquired by Pitney Bowes Inc. (NYSE: PBI), a global shipping and mailing company, in November 2004. She also served as Director of Project Management at Iwerks Entertainment, a designer and manufacturer of software based entertainment attractions, from January 1990 to August 1996.
- James E. Ousley
-
James E. Ousley于1998年6月当选为董事，非执行主席。Ousley先生于2014年8月加入CVC Capital Partners，担任高级运营合伙人。2013年4月，Ousley先生从CenturyLink，Inc.的业务部门萨维斯通信的首席执行官和CenturyLink的企业市场集团“EMG”总裁的职位上退休。Ousley先生于2012年3月被任命为EMG总裁。2009年至2011年，Ousley先生担任萨维斯通信的董事长兼首席执行官。Ousley先生在2002年至2004年期间担任Vytek Wireless Inc.的总裁兼首席执行官。在1999年至2001年期间，他担任英国电信公司（British Telecommunications plc）的一个部门Syntegra（USA）的总裁兼主席。从1991年到1999年，Ousley先生担任Control Data Systems的总裁兼首席执行官。从1968年到1991年，他在Control Data Corporation担任过多个销售和执行管理职位。Ousley先生目前在Chayora，Inc.、Integra，Inc.、Identiv, Inc.、Pacnet，Inc.和Wireless Logic的董事会任职。
James E. Ousley has served as the Chair of the Board since September 2015 and as a director of the Company since July 2014. Mr. Ousley has more than 40 years of experience leading global technology and telecommunications organizations. From February 2025 to March 2026, he served as Chief Executive Officer and President of Vitech, Inc., an insurance industry software, services and SaaS provider. He also served as Senior Operating Managing Partner at CVC Growth Capital, a private equity and investment advisory firm, from July 2014 to June 2025. Previously, Mr. Ousley served as the Chief Executive Officer at Savvis, Inc., a provider of information technology services, from March 2010 to April 2013. Savvis was acquired by Lumen Technologies (formerly CenturyLink), where he served as Chief Executive Officer of Savvis and President of Enterprise Markets Group, which is now CenturyLink Technology Solutions, a global leader in cloud and managed solutions. Prior to Savvis, Mr. Ousley served as President and Chief Executive Officer of Vytek Wireless, Inc., a provider of wireless and mobile computing solutions, which was acquired by CalAmp, Inc., President and Chairman of Syntegra (USA), a division of BT Group plc (formerly British Telecommunications plc), a telecommunications holding company, and President and Chief Executive Officer of Control Data Systems, a technology company which was acquired by BT Group plc. Mr. Ousley has also held various executive management positions with Control Data Corporation, a mainframe and supercomputer firm. - James E. Ousley于1998年6月当选为董事，非执行主席。Ousley先生于2014年8月加入CVC Capital Partners，担任高级运营合伙人。2013年4月，Ousley先生从CenturyLink，Inc.的业务部门萨维斯通信的首席执行官和CenturyLink的企业市场集团“EMG”总裁的职位上退休。Ousley先生于2012年3月被任命为EMG总裁。2009年至2011年，Ousley先生担任萨维斯通信的董事长兼首席执行官。Ousley先生在2002年至2004年期间担任Vytek Wireless Inc.的总裁兼首席执行官。在1999年至2001年期间，他担任英国电信公司（British Telecommunications plc）的一个部门Syntegra（USA）的总裁兼主席。从1991年到1999年，Ousley先生担任Control Data Systems的总裁兼首席执行官。从1968年到1991年，他在Control Data Corporation担任过多个销售和执行管理职位。Ousley先生目前在Chayora，Inc.、Integra，Inc.、Identiv, Inc.、Pacnet，Inc.和Wireless Logic的董事会任职。
- James E. Ousley has served as the Chair of the Board since September 2015 and as a director of the Company since July 2014. Mr. Ousley has more than 40 years of experience leading global technology and telecommunications organizations. From February 2025 to March 2026, he served as Chief Executive Officer and President of Vitech, Inc., an insurance industry software, services and SaaS provider. He also served as Senior Operating Managing Partner at CVC Growth Capital, a private equity and investment advisory firm, from July 2014 to June 2025. Previously, Mr. Ousley served as the Chief Executive Officer at Savvis, Inc., a provider of information technology services, from March 2010 to April 2013. Savvis was acquired by Lumen Technologies (formerly CenturyLink), where he served as Chief Executive Officer of Savvis and President of Enterprise Markets Group, which is now CenturyLink Technology Solutions, a global leader in cloud and managed solutions. Prior to Savvis, Mr. Ousley served as President and Chief Executive Officer of Vytek Wireless, Inc., a provider of wireless and mobile computing solutions, which was acquired by CalAmp, Inc., President and Chairman of Syntegra (USA), a division of BT Group plc (formerly British Telecommunications plc), a telecommunications holding company, and President and Chief Executive Officer of Control Data Systems, a technology company which was acquired by BT Group plc. Mr. Ousley has also held various executive management positions with Control Data Corporation, a mainframe and supercomputer firm.
- Richard E. Kuntz
-
Richard E. Kuntz，他自2010年10月起担任本公司董事。他2009年8月担任美敦力公司高级副总裁兼首席科学人员，首席临床和管理人员。之前，他从2005年10月至2009年8月担任神经调节部门高级副总裁及总裁。在他目前的职位上，他负责监督美敦力公司全球法规事务，卫生政策和报销，临床研究活动，企业和新的治疗方法，战略和创新，企业发展，与收购，整合和资产剥离的业务。他带来了在医疗保健的许多不同领域广阔的背景和专业知识。在美敦力工作之前，他担任哈佛临床研究所（HCRI）（一个以大学为基础的合同研究组织）首席科学家，协调国家卫生研究院（NIH）和工业与美国食品药品监督管理局（FDA）临床试验首席科学官。他曾指导过超过100多中心临床试验，并撰写了200多本原版著作。他还担任哈佛医学院医学副教授，临床生物识别技术部主席，波士顿的伯翰和妇女医院心血管疾病的一个部门的介入心脏病专家。他毕业于迈阿密大学，在凯斯西储大学医学院获得医学学位。他在德州大学西南医学院完成内科住院医师实习，然后在贝斯以色列医院和哈佛医学院完成心血管疾病和介入心脏病学奖学金学业。他获得哈佛大学公共卫生学院生物统计学科学硕士学位。
Richard E. Kuntz, M.D., M.Sc.,has served as a director of Company since October 2010. Dr. Kuntz has served as the Senior Vice President and Chief Scientific, Clinical and Regulatory Officer of Medtronic, Inc. since August 2009 prior to which time he served as the Senior Vice President and President, Neuromodulation from October 2005 to August 2009. In his current role, Dr. Kuntz oversees Medtronic's global regulatory affairs, health policy and reimbursement, clinical research activities, ventures and new therapies, strategy and innovation, corporate development, and acquisitions, integrations and divestitures functions. Prior to Medtronic, he was the Founder and Chief Scientific Officer of the Harvard Clinical Research Institute "HCRI", a university-based contract research organization that coordinates National Institutes of Health ("NIH") and industry clinical trials with the United States Food and Drug Administration ("FDA"). Dr. Kuntz has directed over 100 multicenter clinical trials and has authored more than 200 original publications. Dr. Kuntz also served as Associate Professor of Medicine at Harvard Medical School, Chief of the Division of Clinical Biometrics, and an interventional cardiologist in the division of cardiovascular diseases at the Brigham and Women's Hospital in Boston, MA. Dr. Kuntz graduated from Miami University and received his medical degree from Case Western Reserve University School of Medicine. He completed his residency in internal medicine at the University of Texas Southwestern Medical School, and then completed fellowships in cardiovascular diseases and interventional cardiology at the Beth Israel Hospital and Harvard Medical School, Boston. Dr. Kuntz received his master's of science in biostatistics from the Harvard School of Public Health. - Richard E. Kuntz，他自2010年10月起担任本公司董事。他2009年8月担任美敦力公司高级副总裁兼首席科学人员，首席临床和管理人员。之前，他从2005年10月至2009年8月担任神经调节部门高级副总裁及总裁。在他目前的职位上，他负责监督美敦力公司全球法规事务，卫生政策和报销，临床研究活动，企业和新的治疗方法，战略和创新，企业发展，与收购，整合和资产剥离的业务。他带来了在医疗保健的许多不同领域广阔的背景和专业知识。在美敦力工作之前，他担任哈佛临床研究所（HCRI）（一个以大学为基础的合同研究组织）首席科学家，协调国家卫生研究院（NIH）和工业与美国食品药品监督管理局（FDA）临床试验首席科学官。他曾指导过超过100多中心临床试验，并撰写了200多本原版著作。他还担任哈佛医学院医学副教授，临床生物识别技术部主席，波士顿的伯翰和妇女医院心血管疾病的一个部门的介入心脏病专家。他毕业于迈阿密大学，在凯斯西储大学医学院获得医学学位。他在德州大学西南医学院完成内科住院医师实习，然后在贝斯以色列医院和哈佛医学院完成心血管疾病和介入心脏病学奖学金学业。他获得哈佛大学公共卫生学院生物统计学科学硕士学位。
- Richard E. Kuntz, M.D., M.Sc.,has served as a director of Company since October 2010. Dr. Kuntz has served as the Senior Vice President and Chief Scientific, Clinical and Regulatory Officer of Medtronic, Inc. since August 2009 prior to which time he served as the Senior Vice President and President, Neuromodulation from October 2005 to August 2009. In his current role, Dr. Kuntz oversees Medtronic's global regulatory affairs, health policy and reimbursement, clinical research activities, ventures and new therapies, strategy and innovation, corporate development, and acquisitions, integrations and divestitures functions. Prior to Medtronic, he was the Founder and Chief Scientific Officer of the Harvard Clinical Research Institute "HCRI", a university-based contract research organization that coordinates National Institutes of Health ("NIH") and industry clinical trials with the United States Food and Drug Administration ("FDA"). Dr. Kuntz has directed over 100 multicenter clinical trials and has authored more than 200 original publications. Dr. Kuntz also served as Associate Professor of Medicine at Harvard Medical School, Chief of the Division of Clinical Biometrics, and an interventional cardiologist in the division of cardiovascular diseases at the Brigham and Women's Hospital in Boston, MA. Dr. Kuntz graduated from Miami University and received his medical degree from Case Western Reserve University School of Medicine. He completed his residency in internal medicine at the University of Texas Southwestern Medical School, and then completed fellowships in cardiovascular diseases and interventional cardiology at the Beth Israel Hospital and Harvard Medical School, Boston. Dr. Kuntz received his master's of science in biostatistics from the Harvard School of Public Health.
- Gary Kremen
-
Gary Kremen，自2014年以来一直是该公司的一位董事。他是近40家公司、私募股权基金和风险投资基金的连续的创业家和投资者。他创立的公司包括Match.com、the first dating website、 Clean Power Finance、the leading white-label residential solar finance company等公司。他是一个1995年申请了专利的动态网页的主要发明人，以及拥有金融相关系统管理的3个其它专利。他拥有从Northwestern大学的电气工程和计算机科学学士学位，以及从Stanford大学研究生商学院的工商管理学硕士学位。目前，他是一些私营企业的负责人或者经营合伙人，包括CapGain Solutions 和 Cross Coin Ventures；他还在一些私人机构的董事会任职，这些机构包括WaterSmart Software、 CrowdFlower以及 the Purissima Hills Water District。
Gary Kremen has served as a director of the Company since February 2014. Mr. Kremen is an entrepreneur and has been an investor in over 100 private technology companies, private equity funds and venture capital funds. Companies he has founded or co founded include Match.com (now Match Group), one of the world's largest dating websites, Clean Power Finance (now Spruce Finance), a leading white label residential solar finance company as well as Pace Avenue, a customer acquisition firm marketing renewable energy and energy efficiency solutions to low and moderate income households. Mr. Kremen is credited as the primary inventor on a 1995 filed patent for dynamic web pages as well as four other issued patents. Mr. Kremen serves as a board member and/or principal or managing partner to several private companies, including CapGain Solutions, a provider of financial services, and Voter.vote, a political outreach software company. Previously, Mr. Kremen served on the board of directors of Water Assurance Partners, LLC, a provider of agriculture water services, as well as several non profit entities, including the Santa Clara Valley Water District, San Luis & Delta Mendota Water Authority, San Francisquito Creek Joint Powers Authority, Delta Conveyance Finance Authority, and the University of California Merced Foundation. He holds two B.S. degrees: one in Electrical Engineering and the other in Computer Science, both from Northwestern University, as well as an M.B.A. from the Stanford University Graduate School of Business. - Gary Kremen，自2014年以来一直是该公司的一位董事。他是近40家公司、私募股权基金和风险投资基金的连续的创业家和投资者。他创立的公司包括Match.com、the first dating website、 Clean Power Finance、the leading white-label residential solar finance company等公司。他是一个1995年申请了专利的动态网页的主要发明人，以及拥有金融相关系统管理的3个其它专利。他拥有从Northwestern大学的电气工程和计算机科学学士学位，以及从Stanford大学研究生商学院的工商管理学硕士学位。目前，他是一些私营企业的负责人或者经营合伙人，包括CapGain Solutions 和 Cross Coin Ventures；他还在一些私人机构的董事会任职，这些机构包括WaterSmart Software、 CrowdFlower以及 the Purissima Hills Water District。
- Gary Kremen has served as a director of the Company since February 2014. Mr. Kremen is an entrepreneur and has been an investor in over 100 private technology companies, private equity funds and venture capital funds. Companies he has founded or co founded include Match.com (now Match Group), one of the world's largest dating websites, Clean Power Finance (now Spruce Finance), a leading white label residential solar finance company as well as Pace Avenue, a customer acquisition firm marketing renewable energy and energy efficiency solutions to low and moderate income households. Mr. Kremen is credited as the primary inventor on a 1995 filed patent for dynamic web pages as well as four other issued patents. Mr. Kremen serves as a board member and/or principal or managing partner to several private companies, including CapGain Solutions, a provider of financial services, and Voter.vote, a political outreach software company. Previously, Mr. Kremen served on the board of directors of Water Assurance Partners, LLC, a provider of agriculture water services, as well as several non profit entities, including the Santa Clara Valley Water District, San Luis & Delta Mendota Water Authority, San Francisquito Creek Joint Powers Authority, Delta Conveyance Finance Authority, and the University of California Merced Foundation. He holds two B.S. degrees: one in Electrical Engineering and the other in Computer Science, both from Northwestern University, as well as an M.B.A. from the Stanford University Graduate School of Business.
高管简历
中英对照 | 中文 | 英文- Edward Kirnbauer
Edward Kirnbauer自2025年8月起担任Identiv, Inc.的首席财务官兼秘书，自2015年11月起担任全球公司财务总监。在此之前，Kirnbauer先生于2025年7月至2025年8月期间担任代理首席财务官和代理秘书。自2021年10月至2021年12月，Kirnbauer先生还担任Identiv, Inc.的临时首席财务官、首席财务官和首席会计官。在此之前，2011年4月至2015年11月，Kirnbauer先生曾担任多家公司的财务顾问，包括航空航天和国防公司Ducommun Incorporated（NYSE：DCO）以及科技和电子制造公司Multi Fineline Electronix，Inc.（纳斯达克：MFLX）。在此之前，Kirnbauer先生曾在多家公司担任财务与行政副总裁和公司财务总监，包括在2001年至2006年担任网络附加存储设备开发商Procom Technology，Inc.的公司财务总监。Kirnbauer先生是一名注册会计师，他的职业生涯始于毕马威会计师事务所。Kirnbauer先生拥有DePaul大学Charles H. Kellstadt商学院的工商管理硕士学位和伊利诺伊州立大学的会计学学士学位。
Edward Kirnbauer has served as Identiv, Inc.'s CFO and Secretary since August 2025 and Global Corporate Controller since November 2015. Prior to that, Mr. Kirnbauer served as Acting CFO and Acting Secretary from July 2025 to August 2025. From October 2021 to December 2021, Mr. Kirnbauer also served as Identiv, Inc.'s interim Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer. Previously, from April 2011 to November 2015, Mr. Kirnbauer served as a financial consultant for various companies, including Ducommun Incorporated (NYSE: DCO), an aerospace and defense company, and Multi Fineline Electronix, Inc. (Nasdaq: MFLX), a technology and electronics manufacturing company. Prior to that, Mr. Kirnbauer served as Vice President of Finance & Administration and Corporate Controller at various companies, including as Corporate Controller for Procom Technology, Inc., a developer of network attached storage appliances, from 2001 to 2006. Mr. Kirnbauer is a Certified Public Accountant and started his career at KPMG LLP. Mr. Kirnbauer holds an M.B.A. from DePaul University's Charles H. Kellstadt Graduate School of Business, and a B.S. in Accounting from Illinois State University.- Edward Kirnbauer自2025年8月起担任Identiv, Inc.的首席财务官兼秘书，自2015年11月起担任全球公司财务总监。在此之前，Kirnbauer先生于2025年7月至2025年8月期间担任代理首席财务官和代理秘书。自2021年10月至2021年12月，Kirnbauer先生还担任Identiv, Inc.的临时首席财务官、首席财务官和首席会计官。在此之前，2011年4月至2015年11月，Kirnbauer先生曾担任多家公司的财务顾问，包括航空航天和国防公司Ducommun Incorporated（NYSE：DCO）以及科技和电子制造公司Multi Fineline Electronix，Inc.（纳斯达克：MFLX）。在此之前，Kirnbauer先生曾在多家公司担任财务与行政副总裁和公司财务总监，包括在2001年至2006年担任网络附加存储设备开发商Procom Technology，Inc.的公司财务总监。Kirnbauer先生是一名注册会计师，他的职业生涯始于毕马威会计师事务所。Kirnbauer先生拥有DePaul大学Charles H. Kellstadt商学院的工商管理硕士学位和伊利诺伊州立大学的会计学学士学位。
- Edward Kirnbauer has served as Identiv, Inc.'s CFO and Secretary since August 2025 and Global Corporate Controller since November 2015. Prior to that, Mr. Kirnbauer served as Acting CFO and Acting Secretary from July 2025 to August 2025. From October 2021 to December 2021, Mr. Kirnbauer also served as Identiv, Inc.'s interim Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer. Previously, from April 2011 to November 2015, Mr. Kirnbauer served as a financial consultant for various companies, including Ducommun Incorporated (NYSE: DCO), an aerospace and defense company, and Multi Fineline Electronix, Inc. (Nasdaq: MFLX), a technology and electronics manufacturing company. Prior to that, Mr. Kirnbauer served as Vice President of Finance & Administration and Corporate Controller at various companies, including as Corporate Controller for Procom Technology, Inc., a developer of network attached storage appliances, from 2001 to 2006. Mr. Kirnbauer is a Certified Public Accountant and started his career at KPMG LLP. Mr. Kirnbauer holds an M.B.A. from DePaul University's Charles H. Kellstadt Graduate School of Business, and a B.S. in Accounting from Illinois State University.
- Kirsten Newquist
克尔斯滕·纽奎斯特（Kirsten Newquist）自2024年9月起担任公司首席执行官和董事。在此之前的2024年4月至2024年9月，她担任公司总裁，物联网解决方案。在加入公司之前，她在全球材料科学和数字身份识别解决方案公司艾利丹尼森公司（纽约证券交易所代码：AVY）担任越来越高级的职务，包括2022年10月至2023年9月在艾利丹尼森 Smartrac担任全球医疗保健和产品线管理全球副总裁，2016年6月至2022年10月在艾利丹尼森 Medical担任全球副总裁/总经理，2011年6月至2016年6月在艾利丹尼森 Medical担任全球业务发展副总裁，2007年5月至2011年6月在艾利丹尼森公司担任新增长平台总监。在加入艾利丹尼森之前，Newquist女士于2005年3月至2007年5月期间担任私人投资公司Copia Associates LLC的董事。2001年8月至2005年1月，Newquist女士在Ancora Management Group担任企业发展副总裁，该公司是一家邮件服务公司，于2004年11月被全球航运和邮件公司必能宝公司（NYSE：PBI）收购。她还曾于1990年1月至1996年8月在Iwerks Entertainment担任项目管理总监，Iwerks Entertainment是一家基于软件的娱乐景点的设计者和制造商。
Kirsten Newquist has served as the Company's Chief Executive Officer and as a director of the Company since September 2024. Prior to that, from April 2024 to September 2024, she served as the Company's President, IoT Solutions. Prior to joining the Company, she held increasingly senior roles at Avery Dennison Corporation (NYSE: AVY), a global materials science and digital identification solutions company, including as Global Vice President, Global Healthcare and Product Line Management at Avery Dennison Smartrac from October 2022 to September 2023, Global Vice President/General Manager at Avery Dennison Medical from June 2016 to October 2022, Vice President, Global Business Development at Avery Dennison Medical from June 2011 to June 2016, and Director of New Growth Platforms at Avery Dennison Corporation from May 2007 to June 2011. Prior to Avery Dennison, Ms. Newquist served as a Director at Copia Associates LLC, a private investment firm, from March 2005 to May 2007. From August 2001 to January 2005, Ms. Newquist served as Vice President, Corporate Development at Ancora Management Group, a mail services company that was acquired by Pitney Bowes Inc. (NYSE: PBI), a global shipping and mailing company, in November 2004. She also served as Director of Project Management at Iwerks Entertainment, a designer and manufacturer of software based entertainment attractions, from January 1990 to August 1996.- 克尔斯滕·纽奎斯特（Kirsten Newquist）自2024年9月起担任公司首席执行官和董事。在此之前的2024年4月至2024年9月，她担任公司总裁，物联网解决方案。在加入公司之前，她在全球材料科学和数字身份识别解决方案公司艾利丹尼森公司（纽约证券交易所代码：AVY）担任越来越高级的职务，包括2022年10月至2023年9月在艾利丹尼森 Smartrac担任全球医疗保健和产品线管理全球副总裁，2016年6月至2022年10月在艾利丹尼森 Medical担任全球副总裁/总经理，2011年6月至2016年6月在艾利丹尼森 Medical担任全球业务发展副总裁，2007年5月至2011年6月在艾利丹尼森公司担任新增长平台总监。在加入艾利丹尼森之前，Newquist女士于2005年3月至2007年5月期间担任私人投资公司Copia Associates LLC的董事。2001年8月至2005年1月，Newquist女士在Ancora Management Group担任企业发展副总裁，该公司是一家邮件服务公司，于2004年11月被全球航运和邮件公司必能宝公司（NYSE：PBI）收购。她还曾于1990年1月至1996年8月在Iwerks Entertainment担任项目管理总监，Iwerks Entertainment是一家基于软件的娱乐景点的设计者和制造商。
- Kirsten Newquist has served as the Company's Chief Executive Officer and as a director of the Company since September 2024. Prior to that, from April 2024 to September 2024, she served as the Company's President, IoT Solutions. Prior to joining the Company, she held increasingly senior roles at Avery Dennison Corporation (NYSE: AVY), a global materials science and digital identification solutions company, including as Global Vice President, Global Healthcare and Product Line Management at Avery Dennison Smartrac from October 2022 to September 2023, Global Vice President/General Manager at Avery Dennison Medical from June 2016 to October 2022, Vice President, Global Business Development at Avery Dennison Medical from June 2011 to June 2016, and Director of New Growth Platforms at Avery Dennison Corporation from May 2007 to June 2011. Prior to Avery Dennison, Ms. Newquist served as a Director at Copia Associates LLC, a private investment firm, from March 2005 to May 2007. From August 2001 to January 2005, Ms. Newquist served as Vice President, Corporate Development at Ancora Management Group, a mail services company that was acquired by Pitney Bowes Inc. (NYSE: PBI), a global shipping and mailing company, in November 2004. She also served as Director of Project Management at Iwerks Entertainment, a designer and manufacturer of software based entertainment attractions, from January 1990 to August 1996.